Annals of Internal Medicine November 28, 2017
Eric T. Roberts, PhD; Alan M. Zaslavsky, PhD; J. Michael McWilliams, MD, PhD

Abstract

Background:When risk adjustment is inadequate and incentives are weak, pay-for-performance programs, such as the Value-Based Payment Modifier (Value Modifier [VM]) implemented by the Centers for Medicare & Medicaid Services, may contribute to health care disparities without improving performance on average.
Objective:To estimate the association between VM exposure and performance on quality and spending measures and to assess the effects of adjusting for additional patient characteristics on performance differences between practices serving higher-risk and those serving lower-risk patients.
Design:Exploiting the phase-in of the VM on the basis of practice size, regression discontinuity analysis and 2014 Medicare claims were used to estimate differences in practice performance associated with exposure of practices with 100 or more clinicians to full VM...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: CMS, MACRA, Market Research, Physician
Related Articles:
CMS 2026 Proposed Rules: Key Takeaways for Quality and Stars Managers
AI, IP and Your Healthcare: And You Thought the Doctor’s Exam Was Intrusive!
CMS Plans 4.3% Medicare Advantage Payment Increase for 2026
Practice tip of the week: Making the most of value-based care
Physician recruitment agreements: Understanding signing bonuses, relocation expenses, or loan repayment incentives.

Share This Article